Explore the latest in psoriasis, including advances in understanding the epidemiology, genetics, and management of the disease.
This cohort study evaluates clinical utility of monitoring serum levels of ustekinumab in patients with psoriasis.
This case report describes a series of patients who developed eczema after being treated for psoriasis with secukinumab.
This cohort study describes the prevalence of and evaluates clinical factors associated with advanced liver fibrosis in patients with severe psoriasis.
This cohort study investigates the association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by the perivascular fat attenuation index, an imaging biomarker that assesses coronary inflammation by mapping spatial changes of perivascular fat composition via coronary computed tomography angiography.
This randomized clinical trial evaluates the efficacy and safety of guselkumab in the treatment of patients with palmoplantar pustulosis.
This cross-sectional study investigates the standardized overall comorbidity burden among patients with hidradenitis suppurativa and compares it with the comorbidity burden in patients with psoriasis and a control group.
This cross-sectional study examines the overall subjective and objective evaluation of disease severity between patients with psoriasis who responded “not relevant” vs those who responded “not at all” on the Dermatology Life Quality Index.
This study examines the association between psoriasis and subsequent development of mental disorder using data on individuals with at least 2 hospital- or outpatient-based diagnoses of psoriasis from population-based registries covering all Danish hospitals.
This case-control study uses population-based data to examine the association of psoriasis with mental health disorders, and to identify trends in their rates of occurrence and times to onset after diagnosis of psoriasis.
This cohort study compares the risk of developing atrial fibrillation or major adverse cardiovascular events associated with ustekinumab vs a tumor necrosis factor (TNF) inhibitor therapy among patients with psoriasis or psoriatic arthritis.
This systematic review and meta-analysis assesses whether HLA-C*06:02 status is associated with a differential response in patients with psoriasis after 6 months of ustekinumab therapy.
This cohort study compares the risk of serious infection associated with biologic and nonbiologic systemic medications in patients with psoriasis.
This analysis of aggregate data from electronic medical records assesses the prevalence of atherosclerosis in African American and white patients with psoriasis.
This cohort study compares the effectiveness and adverse effects of methotrexate in Chinese patients with psoriasis with and without psoriatic arthritis.
This study examines the FDA Adverse Event Reporting System and PubMed databases for cases of noninfectious pneumonia acquired after FDA approval of the drug ustekinumab.
This systematic review evaluates the main characteristics of the studies of psoriasis and sexual dysfunction (SD) or erectile dysfunction (ED), including level of evidence, tools used to assess SD or ED, and prevalence and incidence of SD or ED.
This systematic review and meta-analysis of 9 studies comprising more than 7 million patients examines the association between psoriasis and inflammatory bowel disease.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: